Linike Medical Group Ltd
Other OTCTotal Valuation
Linike Medical Group Ltd carries a market capitalization of 6.11M, placing it among publicly traded companies globally.
| Market Cap | 6.11M |
| Enterprise Value | N/A |
Share Statistics
Linike Medical Group Ltd currently has 3.47M shares outstanding.
| Shares Outstanding | 3.47M |
| Owned by Insiders (%) | N/A |
| Owned by Institutions (%) | N/A |
Valuation Ratios
| PE Ratio | N/A |
| PS Ratio | N/A |
| PB Ratio | -108.51 |
| P/TBV Ratio | -114.09 |
| P/FCF Ratio | 605.15 |
| P/OCF Ratio | 605.15 |
Financial Efficiency
| Return on Equity (ROE) | N/A |
| Return on Assets (ROA) | -278.62 |
| Return on Invested Capital (ROIC) | N/A |
| Return on Capital Employed (ROCE) | N/A |
| Revenue Per Employee | N/A |
| Employee Count | N/A |
| Inventory Turnover | N/A |
Stock Price Statistics
Linike Medical Group Ltd's stock has gained approximately 140% over the past 52 weeks. The 50-day moving average sits at 0.02, while the 200-day moving average is 0.02.
| Beta (5Y) | N/A |
| 52-Week Price Change | 140% |
| 50-Day Moving Average | 0.02 |
| 200-Day Moving Average | 0.02 |
| Average Volume (20 Days) | N/A |
Income Statement
EBITDA reached -93,677.00, while operating income came in at -93,673.00.
| Revenue | N/A |
| Gross Profit | N/A |
| Operating Income | -93,673.00 |
| Pretax Income | -306,894.00 |
| Net Income | -306,894.00 |
| EBITDA | -93,677.00 |
| EBIT | -93,673.00 |
| Earnings Per Share (EPS) | -0.09 |
Balance Sheet
Total book value stands at -560,303.00, with working capital of -531,589.00 providing operational flexibility.
| Cash & Cash Equivalents | 149.00 |
| Total Debt | N/A |
| Net Debt | -149.00 |
| Equity (Book Value) | -560,303.00 |
| Book Value Per Share | -0.16 |
| Working Capital | -531,589.00 |
Cash Flow
Linike Medical Group Ltd produced 100,472.00 in operating cash flow over the past twelve months.
| Operating Cash Flow | 100,472.00 |
| Capital Expenditures | N/A |
| Free Cash Flow | 100,472.00 |
| FCF Per Share | 0.03 |
Dividends & Yields
| Dividend Per Share | N/A |
| Dividend Yield | N/A |
| Payout Ratio | N/A |
| Shareholder Yield | 0.48 |
| FCF Yield | 0.17 |
Stock Splits
Linike Medical Group Ltd's most recent stock split took place on June 8, 2020 with a 50:1 split ratio.
| Last Split Date | 6/8/2020 |
| Split Ratio | 50:1 |
Scores
Linike Medical Group Ltd posts an Altman Z-Score of -11,702.31, below the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.
| Altman Z-Score | -11,702.31 |